GH & Growth Peptides
Ipamorelin, CJC-1295, tesamorelin, sermorelin and GH secretagogue research. 13 discussions in this community. Create a free account to ask a question or share your experience.
Discussions in GH & Growth Peptides
- Tesamorelin Fat Quality Study - 3 points, 4 comments
- superman stack trial: no huge pump but gh spikes felt at night - 4 points, 6 comments
- Peptide hype versus evidence: what the science says - 6 points, 4 comments
- GHRP-6 Timing & Hunger Spikes: My 3-Week Test - 3 points, 4 comments
- Does 3x daily GHRP‑2 really hit the GH peak or just make me starving? - 4 points, 4 comments
- Long‑acting CJC‑1295 shows real GH spikes in healthy adults – but is it worth the hype? - 16 points, 5 comments
- Night‑time CJC‑1295/Ipa combo and how it’s shifted my sleep‑GH pulses - 21 points, 4 comments
- Does timing ipamorelin with deep sleep improve morning recovery? - 14 points, 5 comments
- How I timed Ipamorelin with my sleep cycle and what I noticed - 16 points, 4 comments
- NPR is finally noticing the peptide trend - 19 points, 6 comments
- Tesamorelin’s VAT loss: promising marker, uncertain performance - 18 points, 4 comments
- GH pulse timing with GHRP-2 after training, anyone dialled this in? - 8 points, 4 comments
- topol on peptides, finally someone saying the quiet part out loud - 30 points, 6 comments
Related compounds
- AOD-9604 - Advanced Obesity Drug Fragment 176-191 (Modified)
- Semaglutide - Semaglutide (GLP-1 Receptor Agonist)
- Tirzepatide - Tirzepatide (Dual GIP/GLP-1 Receptor Agonist)
- Retatrutide - Retatrutide (Triple Agonist GIP/GLP-1/Glucagon)
- Tesofensine - Tesofensine (Triple Monoamine Reuptake Inhibitor)
- CagriSema - CagriSema (Cagrilintide + Semaglutide)
- Survodutide - Survodutide (Dual GLP-1/Glucagon Agonist)
- Orforglipron - Orforglipron (Oral Non-Peptide GLP-1 Agonist)
Community discussion - research and educational context only. Not medical advice.